Recent progress and application of the tetrahedral framework nucleic acid materials on drug delivery

被引:13
作者
Li, Jiajie [1 ,2 ,3 ]
Yan, Ran [1 ,2 ,3 ]
Shi, Sirong [1 ,2 ,3 ]
Lin, Yunfeng [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
机构
[1] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp Stomatol, Natl Ctr Stomatol, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, Dept Plast Surg & Cosmet Dermatol, Chengdu, Sichuan, Peoples R China
[4] Sichuan Prov Engn Res Ctr Oral Biomat, Chengdu, Sichuan, Peoples R China
[5] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China
[6] Sichuan Univ, West China Hosp Stomatol, Natl Ctr Stomatol, Chengdu 610041, Sichuan, Peoples R China
[7] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, Chengdu 610041, Sichuan, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Tetrahedral framework nucleic acids; drug delivery; passive targeting; active targeting; dynamic response; update iteration; biomedical applications; MESENCHYMAL STEM-CELLS; DNA NANOSTRUCTURES; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; ACTIVATION; PROMOTE; RNA; DIFFERENTIATION; NANOTECHNOLOGY; ENCAPSULATION;
D O I
10.1080/17425247.2023.2276285
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
IntroductionThe application of DNA framework nucleic acid materials in the biomedical field has witnessed continual expansion. Among them, tetrahedral framework nucleic acids (tFNAs) have gained significant traction as the foremost biological vectors due to their superior attributes of editability, low immunogenicity, biocompatibility, and biodegradability. tFNAs have demonstrated promising results in numerous in vitro and in vivo applications.Areas coveredThis review summarizes the latest research on tFNAs in drug delivery, including a discussion of the advantages of tFNAs in regulating biological behaviors, and highlights the updated development and advantageous applications of tFNAs-based nanostructures from static design to dynamically responsive design.Expert opiniontFNAs possess distinct biological regulatory attributes and can be taken up by cells without the requirement of transfection, differentiating them from other biological vectors. tFNAs can be easily physically/chemically modified and seamlessly incorporated with other functional systems. The static design of the tFNAs-based drug delivery system makes it versatile, reproducible, and predictable. Further use of the dynamic response mechanism of DNA to external stimuli makes tFNAs-based drug delivery more effective and specific, improving the uptake and utilization of the payload by the intended target. Dynamic targeting is poised to become the future primary approach for drug delivery.
引用
收藏
页码:1511 / 1530
页数:20
相关论文
共 161 条
[1]   Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics [J].
Akhtar, Amna ;
Andleeb, Anisa ;
Waris, Tayyba Sher ;
Bazzar, Masoomeh ;
Moradi, Ali-Reza ;
Awan, Nasir Raza ;
Yar, Muhammad .
JOURNAL OF CONTROLLED RELEASE, 2021, 330 :1152-1167
[2]   Current Strategies for the Regeneration of Skeletal Muscle Tissue [J].
Alarcin, Emine ;
Bal-ozturk, Ayca ;
Avci, Huseyin ;
Ghorbanpoor, Hamed ;
Dogan Guzel, Fatma ;
Akpek, Ali ;
Yesiltas, Gozde ;
Canak-Ipek, Tuba ;
Avci-Adali, Meltem .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
[3]  
AN S., 2023, CANCERS, V15, P58, DOI [10.3390/cancers15072151, DOI 10.3390/CANCERS15072151]
[4]  
Bagetta G., 2015, NEW TRENDS BASIC CLI
[5]   Acute kidney injury [J].
Bellomo, Rinaldo ;
Kellum, John A. ;
Ronco, Claudio .
LANCET, 2012, 380 (9843) :756-766
[6]   BRANCHED DNA MOLECULES - INTERMEDIATES IN T4 RECOMBINATION [J].
BROKER, TR ;
LEHMAN, IR .
JOURNAL OF MOLECULAR BIOLOGY, 1971, 60 (01) :131-&
[7]   Tetrahedral Framework Nucleic Acids Based Small Interfering RNA Targeting Receptor for Advanced Glycation End Products for Diabetic Complications Treatment [J].
Cai, Zhengwen ;
Li, Yong ;
Bai, Long ;
Xu, Jiangshan ;
Liu, Zhiqiang ;
Zhang, Tianxu ;
Gao, Shaojingya ;
Lin, Yunfeng .
ACS NANO, 2023, 17 (22) :22668-22683
[8]   MUC1 aptamer-targeted DNA micelles for dual tumor therapy using doxorubicin and KLA peptide [J].
Charbgoo, Fahimeh ;
Alibolandi, Mona ;
Taghdisi, Seyed Mohammad ;
Abnous, Khalil ;
Soltani, Fatemeh ;
Ramezani, Mohammad .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2018, 14 (03) :685-697
[9]   Treatment effect of DNA framework nucleic acids on diffuse microvascular endothelial cell injury after subarachnoid hemorrhage [J].
Chen, Ruiqi ;
Wen, Dingke ;
Fu, Wei ;
Xing, Lu ;
Ma, Lu ;
Liu, Yi ;
Li, Hao ;
You, Chao ;
Lin, Yunfeng .
CELL PROLIFERATION, 2022, 55 (04)
[10]   Size-Independent Transmembrane Transporting of Single Tetrahedral DNA Nanostructures [J].
Chen, Xi ;
Tian, Falin ;
Li, Min ;
Xu, Haijiao ;
Cai, Mingjun ;
Li, Qian ;
Zuo, Xiaolei ;
Wang, Hongda ;
Shi, Xinghua ;
Fan, Chunhai ;
Baigude, Huricha ;
Shan, Yuping .
GLOBAL CHALLENGES, 2020, 4 (03)